Antidiabetic GLP-1 Agonist Limit
Antidiabetic GLP-1 Agonist Limit Policy 4525-H 08-2021.pdf
PDF
• 72.62 KB
- January 11, 2022
- ADLYXIN (lixisenatide)
- BYDUREON (exenatide extended-release)
- BYDUREON BCISE (exenatide extended-release)
- BYETTA (exenatide)
- OZEMPIC (semaglutide)
- RYBELSUS (semaglutide)
- TRULICITY (dulaglutide)
- VICTOZA (liraglutide)
First Published
Last Updated